Why the study?
Increasing rates of obesity, diabetes, and an aging population have led to a significant proportion of patients with challenging multivessel coronary disease alongside recent advancements in percutaneous management.
This review summarizes the evidence base underpinning multivessel percutaneous coronary intervention in stable and acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Consolidates multivessel PCI evidence; leaves open optimal strategies by syndrome and patient subset.
Coronary disease carries significant morbidity and mortality globally. The pandemic of obesity and diabetes combined with an aging population have resulted in a significant proportion of patients with multivessel coronary disease, the management of which poses significant challenges. A number of advancements in coronary intervention have emerged in the last few years allowing effective percutaneous management of complex coronary disease. In this review we examine the evidence base underpinning multivessel percutaneous coronary intervention across the spectrum of stable and acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Akbari et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: